| Bid Price | 1936.00p | High Price | 1944.00p |
|---|
| Ask Price | 1938.00p | Low Price | 1926.00p |
|---|
| Open Price | 1942.00p | Spread | 0.10% |
|---|
| Prev Close | 1939.00p | Volume | 478,848 |
|---|
Hikma Pharmaceuticals PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Aug 1, 2025 | 1936.00 | 1953.00 | 1925.00 | 1939.00 | 1,793,549 |
| Jul 31, 2025 | 2002.00 | 2004.00 | 1962.00 | 1964.00 | 1,887,041 |
| Jul 30, 2025 | 1983.00 | 1999.00 | 1961.86 | 1995.00 | 231,338 |
| Jul 29, 2025 | 1986.00 | 2002.00 | 1976.00 | 1976.00 | 293,926 |
| Jul 28, 2025 | 2024.00 | 2024.00 | 1992.00 | 1992.00 | 242,180 |
Hikma Pharmaceuticals PLC Information
| Name | Hikma Pharmaceuticals PLC | Index | FTSE 100 |
|---|
| ISIN | GB00B0LCW083 | Epic | HIK |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET1 |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 500 | Trading Status | Post Trading |
|---|
| Shares in Issue | 220.43 m | Prev Close | 1939.00p |
|---|
| PE Ratio | 15.90715 | Market Cap | £4.26 bn |
|---|
| Div Yield | 3.17 | Div per Share | $0.32 |
|---|
| EPS | $0.60 | Div Cover | 1.8834 |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | 0.042827 | DPS Growth (%) | 0.2735 |
|---|
| Current Ratio | 1.144085 | Quick Ratio | 0.565217 |
|---|
Hikma Pharmaceuticals PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 03/06/25 | TIN | Mazen Darwazah | CH | 36,171 @ £0.00 | £0.00 |
| 03/06/25 | TIN | Said Darwazah | CEO | 31,679 @ £0.00 | £0.00 |
| 03/06/25 | SELL | Riad Mishlawi | CEO | 13,863 @ £21.38 | £296,391.00 |
| 03/06/25 | TIN | Riad Mishlawi | CEO | 36,371 @ £0.00 | £0.00 |
| 08/05/25 | DRIP | Riad Mishlawi | CEO | 1,454 @ £20.23 | £29,414.00 |
| 04/03/25 | TIN | Mazen Darwazah | CH | 14,844 @ £0.00 | £0.00 |
| 04/03/25 | TIN | Said Darwazah | CEO | 18,420 @ £0.00 | £0.00 |
| 04/03/25 | EXR | Riad Mishlawi | CEO | 19,890 @ £0.00 | £0.00 |
| 04/03/25 | TIN | Riad Mishlawi | CEO | 18,691 @ £0.00 | £0.00 |
| 24/09/24 | DRIP | Riad Mishlawi | CEO | 509 @ £19.03 | £9,686.00 |
Hikma Pharmaceuticals PLC News
